Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Tandem Diabetes to acquire Swiss insulin pump maker AMF Medical
06:40am, Tuesday, 13'th Dec 2022
Tandem Diabetes Care Inc. TNDM, +1.21% , an insulin delivery and diabetes technology company, said Tuesday it has entered a definitive agreement to acquire AMF Medical SA, a Swiss privately held maker
Buy These 2 Beaten-Growth Stocks Before They Soar
02:53pm, Friday, 11'th Nov 2022 The Motley Fool
You'll thank me down the road.
Buy These 2 Beaten-Growth Stocks Before They Soar
09:53am, Friday, 11'th Nov 2022
You'll thank me down the road.
Tandem Diabetes (TNDM) Q3 Earnings Miss, Sales View Cut
11:20am, Monday, 07'th Nov 2022
Tandem Diabetes (TNDM) defers $0.6 million of United States pump sales as a result of Tandem Choice.
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
10:06am, Friday, 04'th Nov 2022 Benzinga
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Lincoln National Corporation (NYS
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
08:41am, Friday, 04'th Nov 2022 Benzinga
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Acutus
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
06:35pm, Thursday, 03'rd Nov 2022 Benzinga
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.
Virax Biolabs Group Limited (NASDAQ: VRAX) surged 34% to $2.25 after the company announced the distribution of a RSV-I
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Misses Revenue Estimates
10:35pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -800% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the
This insulin-pump company's stock is plunging, and executives say it's because diabetics in U.S. can't afford the technology
09:51pm, Wednesday, 02'nd Nov 2022 MarketWatch
Tandem Diabetes Care Inc. shares plummeted more than 20% after the company reported earnings Wednesday, continuing a decline that has already cost the company two-thirds of its market value this year.
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Misses Revenue Estimates
08:20pm, Wednesday, 02'nd Nov 2022
Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -800% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the
Zacks.com featured highlights include Tandem Diabetes Care, Krispy Kreme, Caesars Entertainment and Vestas Wind Systems
11:29am, Tuesday, 01'st Nov 2022 Zacks Investment Research
Tandem Diabetes Care, Krispy Kreme, Caesars Entertainment and Vestas Wind Systems are part of Zacks Screen of the week article.
RxSight, Inc. (RXST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
02:01pm, Monday, 31'st Oct 2022 Zacks Investment Research
RxSight, Inc. (RXST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Get Rid of Your Stress by Dumping These 4 Toxic Stocks
12:41pm, Monday, 31'st Oct 2022 Zacks Investment Research
Detoxify your portfolio by selling stocks like Tandem Diabetes (TNDM) Krispy Kreme (DNUT), Caesars Entertainment (CZR) and Vestas Wind (VWDRY).
Get Rid of Your Stress by Dumping These 4 Toxic Stocks
09:47am, Monday, 31'st Oct 2022
Detoxify your portfolio by selling stocks like Tandem Diabetes (TNDM) Krispy Kreme (DNUT), Caesars Entertainment (CZR) and Vestas Wind (VWDRY).
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q3 Earnings Expected to Decline
02:01pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
